Cle De Peau Beaute Protective Day Emulsion
NDC Package 58411-953-10
Package Information
Cle De Peau Beaute Protective Day (avobenzone, octinoxate, octocrylene) emulsions is a human otc drug administered via topical route. This formulation utilizes a emulsion delivery system. Marketed by Shiseido Americas Corporation, this product is identified by NDC 58411-953 and is authorized under FDA application M020.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 58411 - Shiseido Americas Corporation
- 58411-953 - Cle De Peau Beaute Protective Day
- 58411-953-10 - 1 BOTTLE, GLASS in 1 BOX / 125 mL in 1 BOTTLE, GLASS
- 58411-953 - Cle De Peau Beaute Protective Day
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (58411-953). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 58411-953-10 identifies a specific commercial package of 1 bottle, glass in 1 box / 125 ml in 1 bottle, glass of Cle De Peau Beaute Protective Day, a human over the counter drug labeled by Shiseido Americas Corporation. This emulsion is formulated for topical use and contains avobenzone; octinoxate; octocrylene as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Shiseido Americas Corporation on February 02, 2025. The current certification is valid through December 31, 2027.
How is this Shiseido Americas Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 58411095310. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.